enGenes Biotech has developed customized solutions for the cost-effective production of recombinant proteins in microbial expression systems.
The solutions are leveraged from enGenes’ world-class experience in cutting-edge genetic engineering, combined with a broad expertise in bioprocess engineering, to produce best-in-class protein expression systems.
The company’s unique enGenes-eXpress™ Escherichia coli (E.coli) proprietary technology forms a production platform that achieves outstanding yields of soluble and active recombinant protein by reducing biological complexity. This is achieved by decoupling biomass growth from product formation.
For more information follow https://www.pharmaceutical-networking.com/cost-effective-recombinant-protein-production/
Comments